ALLIANCEBERNSTEIN L.P. - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 119 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2018. The put-call ratio across all filers is 1.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q2 2024$469,280
-53.8%
342,540
+26.5%
0.00%
Q1 2024$1,015,238
-61.8%
270,7300.0%0.00%
-100.0%
Q4 2023$2,655,861
+20.6%
270,730
+2.6%
0.00%0.0%
Q3 2023$2,202,981
-44.9%
263,830
-12.2%
0.00%
-50.0%
Q2 2023$3,997,049
+50.5%
300,530
+31.1%
0.00%
+100.0%
Q1 2023$2,655,294
+35.6%
229,300
-4.2%
0.00%0.0%
Q4 2022$1,957,474
+38.3%
239,300
-1.8%
0.00%0.0%
Q3 2022$1,415,000
+31.4%
243,7000.0%0.00%
Q2 2022$1,077,000
-51.7%
243,700
-0.4%
0.00%
-100.0%
Q1 2022$2,228,000
-55.4%
244,800
+0.2%
0.00%
-50.0%
Q4 2021$4,996,000
-19.9%
244,2000.0%0.00%0.0%
Q3 2021$6,239,000
-27.4%
244,200
-0.6%
0.00%
-33.3%
Q2 2021$8,589,000
+7.8%
245,600
+2.7%
0.00%0.0%
Q1 2021$7,968,000
+19.7%
239,200
-6.7%
0.00%0.0%
Q4 2020$6,654,000
+198.4%
256,500
+13.5%
0.00%
+200.0%
Q3 2020$2,230,000
+229.4%
225,900
+15.1%
0.00%
Q2 2020$677,000
+12.6%
196,3000.0%0.00%
Q1 2020$601,000
-89.3%
196,300
-82.1%
0.00%
-100.0%
Q4 2019$5,629,000
+35.7%
1,095,128
+36.3%
0.00%0.0%
Q3 2019$4,147,000
-8.4%
803,733
+7.4%
0.00%0.0%
Q2 2019$4,529,000
+58.4%
748,558
+89.3%
0.00%
+50.0%
Q1 2019$2,859,000
-13.5%
395,379
-11.5%
0.00%0.0%
Q4 2018$3,307,000
+334.6%
446,857
+217.6%
0.00%
Q3 2018$761,000
+52.5%
140,7000.0%0.00%
Q2 2018$499,000
+109.7%
140,700
+21.3%
0.00%
Q1 2018$238,000
-12.5%
116,000
+12.6%
0.00%
Q4 2017$272,000
-49.7%
103,0000.0%0.00%
Q3 2017$541,000
+32.9%
103,000
-9.8%
0.00%
Q2 2017$407,000
+0.2%
114,200
+45.5%
0.00%
Q1 2017$406,000
+36.2%
78,5000.0%0.00%
Q4 2016$298,000
-61.2%
78,500
-8.5%
0.00%
-100.0%
Q3 2016$769,000
+27.3%
85,8000.0%0.00%0.0%
Q2 2016$604,000
-15.0%
85,800
+2.6%
0.00%0.0%
Q1 2016$711,000
-47.8%
83,600
-19.5%
0.00%0.0%
Q4 2015$1,363,000
+289.4%
103,800
+8.5%
0.00%
Q3 2015$350,000
-36.5%
95,7000.0%0.00%
Q2 2015$551,000
+3.8%
95,700
+5.3%
0.00%
Q1 2015$531,000
-29.9%
90,900
-5.8%
0.00%
-100.0%
Q4 2014$757,000
+100.3%
96,500
+25.5%
0.00%
Q3 2014$378,000
-20.4%
76,9000.0%0.00%
Q2 2014$475,000
+13.1%
76,900
-2.1%
0.00%
Q1 2014$420,000
+2.2%
78,5220.0%0.00%
Q4 2013$411,000
-15.6%
78,522
-10.9%
0.00%
Q3 2013$487,000
+20.8%
88,122
-44.9%
0.00%
Q2 2013$403,000160,0070.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q3 2018
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 2,557,764$18,927,0005.87%
HAVENS ADVISORS LLC 626,000$4,632,0004.30%
STANSBERRY ASSET MANAGEMENT, LLC 1,091,124$8,074,0002.54%
BARDIN HILL MANAGEMENT PARTNERS LP 1,580,177$11,693,0002.28%
Trellus Management Company, LLC 111,000$821,0001.86%
Fort Baker Capital Management LP 451,000$3,337,0001.79%
Versor Investments LP 1,014,432$7,507,0001.72%
Magnetar Financial LLC 9,282,677$68,692,0001.68%
BOURNE LENT ASSET MANAGEMENT INC 335,650$2,484,0001.47%
Consonance Capital Management LP 2,455,114$18,168,0001.34%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders